Nasa Rhinathiol (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride selectively stimulates alpha‑1 adrenergic receptors on the smooth muscle of nasal blood vessels. This causes vasoconstriction, reducing mucosal edema and opening the airway for easier breathing.

The appropriate dose and frequency are determined by a qualified healthcare professional based on the patient’s age, condition, and response. Users should follow the prescriber’s instructions and the product label.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasa Rhinathiol’s active ingredient, Xylometazoline, is a selective alpha‑1 agonist offering rapid relief with a relatively low risk of systemic side effects compared with non‑selective agents. It is comparable in efficacy to oxymetazoline but may have a slightly different safety profile, especially regarding rebound congestion.

Store the nasal spray at room temperature, preferably below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and children. Do not freeze the product.

Nasa Rhinathiol is applied intranasally. The recommended method is to gently tilt the head forward, insert the spray tip into one nostril, and press the pump to deliver the prescribed number of sprays, then repeat in the other nostril if directed.

Serious risks, though rare, include severe hypertension, cardiac arrhythmias, nasal septum perforation, and anaphylactic reactions. Users should discontinue use and seek medical attention if they experience chest pain, rapid heartbeat, severe headache, or signs of an allergic reaction.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation, patients with uncontrolled hypertension, severe coronary artery disease, or those who have had recent nasal surgery should avoid using Nasa Rhinathiol unless advised otherwise by a healthcare professional.